{"podcast":{"title":"Neurology Minute","slug":"neurology-minute-15117","podcast_index_feed_id":15117,"rss_url":"https://neurologyminute.libsyn.com/rss","website_url":"https://www.aan.com/education-and-research/online-learning-programs/podcasts/neurology-minute-podcast","image_url":"https://static.libsyn.com/p/assets/3/0/c/3/30c3c82925660375e55e3c100dce7605/NM_PodcastIcon_1400x1400.png","author":"Anna Rehbein","episode_count":1956,"summary":"The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.","last_synced_at":"2026-06-25T18:20:17.428469+00:00","page_url":"https://stenobird.com/podcast/neurology-minute-15117"},"episode":{"title":"Diagnostic Utility and Prognostic Significance of Circulating Tumor Cell Assay CNSide in Patients With Suspicion for Leptomeningeal Metastases - Part 1","slug":"diagnostic-utility-and-prognostic-significance-of-circulating-tumor-cell-assay-cnside-in-patients-with-suspicion-for-leptomeningeal-metastases-part-1","published_at":"2026-04-15T08:30:00+00:00","page_url":"https://stenobird.com/podcast/neurology-minute-15117/diagnostic-utility-and-prognostic-significance-of-circulating-tumor-cell-assay-cnside-in-patients-with-suspicion-for-leptomeningeal-metastases-part-1","show_page_url":"https://stenobird.com/podcast/neurology-minute-15117","url":"https://neurologyminute.libsyn.com/diagnostic-utility-and-prognostic-significance-of-circulating-tumor-cell-assay-cnside-in-patients-with-suspicion-for-leptomeningeal-metastases-part-1","audio_url":"https://traffic.libsyn.com/secure/neurologyminute/03_April_15th_2026_nm_v2_1.mp3?dest-id=1085030","summary":"In the first part of this series, Dr. Justin Abbatemarco and Dr. Shreya Louis discuss the background and evolving terminology around circulating tumor DNA, cell‑free DNA and CSF‑based testing in neurology. Read more about this abstract on the AAN website .","meta_description":"In the first part of this series, Dr. Justin Abbatemarco and Dr. Shreya Louis discuss the background and evolving terminology around circulating tumor DNA…","key_points":[],"chapters":[],"topics":[],"duration_seconds":265,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/neurology-minute-15117/episodes/diagnostic-utility-and-prognostic-significance-of-circulating-tumor-cell-assay-cnside-in-patients-with-suspicion-for-leptomeningeal-metastases-part-1/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/neurology-minute-15117/diagnostic-utility-and-prognostic-significance-of-circulating-tumor-cell-assay-cnside-in-patients-with-suspicion-for-leptomeningeal-metastases-part-1.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}